Rumors of B-ABSSSI's death are greatly exaggerated particularly due to our current market cap. I suspect partners were offering significantly less than Leo was looking for at the time.
With hindsight including two wasted Prurisol trials would it have been smarter to buckle down and do B-ABSSSI? Possibly, but that's not the path we took.
I believe B-ABSSSI will be advanced into a phase 3 by IPIX or an acquiring company.
Market Data 
Markets 
AI
